Global Muscarinic Acetylcholine Receptor Market Growth (Status and Outlook) 2022-2028
- LP 4754446
- 88 Pages
- January 2022
- Pharmaceuticals
The United States Muscarinic Acetylcholine Receptor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Muscarinic Acetylcholine Receptor market, reaching US$ million by the year 2028. As for the Europe Muscarinic Acetylcholine Receptor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Muscarinic Acetylcholine Receptor players cover Anavex Life Sciences Corp, AstraZeneca Plc, Heptares Therapeutics Ltd, and Karuna Pharmaceuticals Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Muscarinic Acetylcholine Receptor market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
M1
M4
M5
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Anavex Life Sciences Corp
AstraZeneca Plc
Heptares Therapeutics Ltd
Karuna Pharmaceuticals Inc
NeuroHealing Pharmaceuticals Inc
Sumitomo Dainippon Pharma Co Ltd
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Muscarinic Acetylcholine Receptor Market Size 2017-2028
2.1.2 Muscarinic Acetylcholine Receptor Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Muscarinic Acetylcholine Receptor Segment by Type
2.2.1 M1
2.2.2 M4
2.2.3 M5
2.2.4 Others
2.3 Muscarinic Acetylcholine Receptor Market Size by Type
2.3.1 Muscarinic Acetylcholine Receptor Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Muscarinic Acetylcholine Receptor Market Size Market Share by Type (2017-2022)
2.4 Muscarinic Acetylcholine Receptor Segment by Application
2.4.1 Attention Deficit Hyperactivity Disorder
2.4.2 Psychiatric Disorders
2.4.3 Alzheimer's Disease
2.4.4 Chronic Obstructive Pulmonary Disease
2.4.5 Memory Impairment
2.5 Muscarinic Acetylcholine Receptor Market Size by Application
2.5.1 Muscarinic Acetylcholine Receptor Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Muscarinic Acetylcholine Receptor Market Size Market Share by Application (2017-2022)
3 Muscarinic Acetylcholine Receptor Market Size by Player
3.1 Muscarinic Acetylcholine Receptor Market Size Market Share by Players
3.1.1 Global Muscarinic Acetylcholine Receptor Revenue by Players (2020-2022)
3.1.2 Global Muscarinic Acetylcholine Receptor Revenue Market Share by Players (2020-2022)
3.2 Global Muscarinic Acetylcholine Receptor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Muscarinic Acetylcholine Receptor by Regions
4.1 Muscarinic Acetylcholine Receptor Market Size by Regions (2017-2022)
4.2 Americas Muscarinic Acetylcholine Receptor Market Size Growth (2017-2022)
4.3 APAC Muscarinic Acetylcholine Receptor Market Size Growth (2017-2022)
4.4 Europe Muscarinic Acetylcholine Receptor Market Size Growth (2017-2022)
4.5 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size Growth (2017-2022)
5 Americas
5.1 Americas Muscarinic Acetylcholine Receptor Market Size by Country (2017-2022)
5.2 Americas Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022)
5.3 Americas Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Muscarinic Acetylcholine Receptor Market Size by Region (2017-2022)
6.2 APAC Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022)
6.3 APAC Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Muscarinic Acetylcholine Receptor by Country (2017-2022)
7.2 Europe Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022)
7.3 Europe Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Muscarinic Acetylcholine Receptor by Region (2017-2022)
8.2 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022)
8.3 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Muscarinic Acetylcholine Receptor Market Forecast
10.1 Global Muscarinic Acetylcholine Receptor Forecast by Regions (2023-2028)
10.1.1 Global Muscarinic Acetylcholine Receptor Forecast by Regions (2023-2028)
10.1.2 Americas Muscarinic Acetylcholine Receptor Forecast
10.1.3 APAC Muscarinic Acetylcholine Receptor Forecast
10.1.4 Europe Muscarinic Acetylcholine Receptor Forecast
10.1.5 Middle East & Africa Muscarinic Acetylcholine Receptor Forecast
10.2 Americas Muscarinic Acetylcholine Receptor Forecast by Country (2023-2028)
10.2.1 United States Muscarinic Acetylcholine Receptor Market Forecast
10.2.2 Canada Muscarinic Acetylcholine Receptor Market Forecast
10.2.3 Mexico Muscarinic Acetylcholine Receptor Market Forecast
10.2.4 Brazil Muscarinic Acetylcholine Receptor Market Forecast
10.3 APAC Muscarinic Acetylcholine Receptor Forecast by Region (2023-2028)
10.3.1 China Muscarinic Acetylcholine Receptor Market Forecast
10.3.2 Japan Muscarinic Acetylcholine Receptor Market Forecast
10.3.3 Korea Muscarinic Acetylcholine Receptor Market Forecast
10.3.4 Southeast Asia Muscarinic Acetylcholine Receptor Market Forecast
10.3.5 India Muscarinic Acetylcholine Receptor Market Forecast
10.3.6 Australia Muscarinic Acetylcholine Receptor Market Forecast
10.4 Europe Muscarinic Acetylcholine Receptor Forecast by Country (2023-2028)
10.4.1 Germany Muscarinic Acetylcholine Receptor Market Forecast
10.4.2 France Muscarinic Acetylcholine Receptor Market Forecast
10.4.3 UK Muscarinic Acetylcholine Receptor Market Forecast
10.4.4 Italy Muscarinic Acetylcholine Receptor Market Forecast
10.4.5 Russia Muscarinic Acetylcholine Receptor Market Forecast
10.5 Middle East & Africa Muscarinic Acetylcholine Receptor Forecast by Region (2023-2028)
10.5.1 Egypt Muscarinic Acetylcholine Receptor Market Forecast
10.5.2 South Africa Muscarinic Acetylcholine Receptor Market Forecast
10.5.3 Israel Muscarinic Acetylcholine Receptor Market Forecast
10.5.4 Turkey Muscarinic Acetylcholine Receptor Market Forecast
10.5.5 GCC Countries Muscarinic Acetylcholine Receptor Market Forecast
10.6 Global Muscarinic Acetylcholine Receptor Forecast by Type (2023-2028)
10.7 Global Muscarinic Acetylcholine Receptor Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Anavex Life Sciences Corp
11.1.1 Anavex Life Sciences Corp Company Information
11.1.2 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product Offered
11.1.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Anavex Life Sciences Corp Main Business Overview
11.1.5 Anavex Life Sciences Corp Latest Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Information
11.2.2 AstraZeneca Plc Muscarinic Acetylcholine Receptor Product Offered
11.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AstraZeneca Plc Main Business Overview
11.2.5 AstraZeneca Plc Latest Developments
11.3 Heptares Therapeutics Ltd
11.3.1 Heptares Therapeutics Ltd Company Information
11.3.2 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product Offered
11.3.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Heptares Therapeutics Ltd Main Business Overview
11.3.5 Heptares Therapeutics Ltd Latest Developments
11.4 Karuna Pharmaceuticals Inc
11.4.1 Karuna Pharmaceuticals Inc Company Information
11.4.2 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product Offered
11.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Karuna Pharmaceuticals Inc Main Business Overview
11.4.5 Karuna Pharmaceuticals Inc Latest Developments
11.5 NeuroHealing Pharmaceuticals Inc
11.5.1 NeuroHealing Pharmaceuticals Inc Company Information
11.5.2 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product Offered
11.5.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 NeuroHealing Pharmaceuticals Inc Main Business Overview
11.5.5 NeuroHealing Pharmaceuticals Inc Latest Developments
11.6 Sumitomo Dainippon Pharma Co Ltd
11.6.1 Sumitomo Dainippon Pharma Co Ltd Company Information
11.6.2 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product Offered
11.6.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Sumitomo Dainippon Pharma Co Ltd Main Business Overview
11.6.5 Sumitomo Dainippon Pharma Co Ltd Latest Developments
12 Research Findings and Conclusion
Table 1. Muscarinic Acetylcholine Receptor Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of M1
Table 3. Major Players of M4
Table 4. Major Players of M5
Table 5. Major Players of Others
Table 6. Muscarinic Acetylcholine Receptor Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Muscarinic Acetylcholine Receptor Market Size Market Share by Type (2017-2022)
Table 9. Muscarinic Acetylcholine Receptor Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Muscarinic Acetylcholine Receptor Market Size Market Share by Application (2017-2022)
Table 12. Global Muscarinic Acetylcholine Receptor Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Player (2020-2022)
Table 14. Muscarinic Acetylcholine Receptor Key Players Head office and Products Offered
Table 15. Muscarinic Acetylcholine Receptor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Muscarinic Acetylcholine Receptor Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Muscarinic Acetylcholine Receptor Market Size Market Share by Regions (2017-2022)
Table 20. Americas Muscarinic Acetylcholine Receptor Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Muscarinic Acetylcholine Receptor Market Size Market Share by Country (2017-2022)
Table 22. Americas Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Muscarinic Acetylcholine Receptor Market Size Market Share by Type (2017-2022)
Table 24. Americas Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Muscarinic Acetylcholine Receptor Market Size Market Share by Application (2017-2022)
Table 26. APAC Muscarinic Acetylcholine Receptor Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Muscarinic Acetylcholine Receptor Market Size Market Share by Region (2017-2022)
Table 28. APAC Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Muscarinic Acetylcholine Receptor Market Size Market Share by Type (2017-2022)
Table 30. APAC Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Muscarinic Acetylcholine Receptor Market Size Market Share by Application (2017-2022)
Table 32. Europe Muscarinic Acetylcholine Receptor Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Muscarinic Acetylcholine Receptor Market Size Market Share by Country (2017-2022)
Table 34. Europe Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Muscarinic Acetylcholine Receptor Market Size Market Share by Type (2017-2022)
Table 36. Europe Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Muscarinic Acetylcholine Receptor Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Muscarinic Acetylcholine Receptor
Table 45. Key Market Challenges & Risks of Muscarinic Acetylcholine Receptor
Table 46. Key Industry Trends of Muscarinic Acetylcholine Receptor
Table 47. Global Muscarinic Acetylcholine Receptor Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Muscarinic Acetylcholine Receptor Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Muscarinic Acetylcholine Receptor Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Muscarinic Acetylcholine Receptor Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Muscarinic Acetylcholine Receptor Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Muscarinic Acetylcholine Receptor Market Size Market Share Forecast by Application (2023-2028)
Table 53. Anavex Life Sciences Corp Details, Company Type, Muscarinic Acetylcholine Receptor Area Served and Its Competitors
Table 54. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product Offered
Table 55. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Anavex Life Sciences Corp Main Business
Table 57. Anavex Life Sciences Corp Latest Developments
Table 58. AstraZeneca Plc Details, Company Type, Muscarinic Acetylcholine Receptor Area Served and Its Competitors
Table 59. AstraZeneca Plc Muscarinic Acetylcholine Receptor Product Offered
Table 60. AstraZeneca Plc Main Business
Table 61. AstraZeneca Plc Muscarinic Acetylcholine Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. AstraZeneca Plc Latest Developments
Table 63. Heptares Therapeutics Ltd Details, Company Type, Muscarinic Acetylcholine Receptor Area Served and Its Competitors
Table 64. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product Offered
Table 65. Heptares Therapeutics Ltd Main Business
Table 66. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Heptares Therapeutics Ltd Latest Developments
Table 68. Karuna Pharmaceuticals Inc Details, Company Type, Muscarinic Acetylcholine Receptor Area Served and Its Competitors
Table 69. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product Offered
Table 70. Karuna Pharmaceuticals Inc Main Business
Table 71. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Karuna Pharmaceuticals Inc Latest Developments
Table 73. NeuroHealing Pharmaceuticals Inc Details, Company Type, Muscarinic Acetylcholine Receptor Area Served and Its Competitors
Table 74. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product Offered
Table 75. NeuroHealing Pharmaceuticals Inc Main Business
Table 76. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. NeuroHealing Pharmaceuticals Inc Latest Developments
Table 78. Sumitomo Dainippon Pharma Co Ltd Details, Company Type, Muscarinic Acetylcholine Receptor Area Served and Its Competitors
Table 79. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product Offered
Table 80. Sumitomo Dainippon Pharma Co Ltd Main Business
Table 81. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Sumitomo Dainippon Pharma Co Ltd Latest Developments
List of Figures
Figure 1. Muscarinic Acetylcholine Receptor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Muscarinic Acetylcholine Receptor Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Muscarinic Acetylcholine Receptor Market Size Market Share by Type in 2021
Figure 7. Muscarinic Acetylcholine Receptor in Attention Deficit Hyperactivity Disorder
Figure 8. Global Muscarinic Acetylcholine Receptor Market: Attention Deficit Hyperactivity Disorder (2017-2022) & ($ Millions)
Figure 9. Muscarinic Acetylcholine Receptor in Psychiatric Disorders
Figure 10. Global Muscarinic Acetylcholine Receptor Market: Psychiatric Disorders (2017-2022) & ($ Millions)
Figure 11. Muscarinic Acetylcholine Receptor in Alzheimer's Disease
Figure 12. Global Muscarinic Acetylcholine Receptor Market: Alzheimer's Disease (2017-2022) & ($ Millions)
Figure 13. Muscarinic Acetylcholine Receptor in Chronic Obstructive Pulmonary Disease
Figure 14. Global Muscarinic Acetylcholine Receptor Market: Chronic Obstructive Pulmonary Disease (2017-2022) & ($ Millions)
Figure 15. Muscarinic Acetylcholine Receptor in Memory Impairment
Figure 16. Global Muscarinic Acetylcholine Receptor Market: Memory Impairment (2017-2022) & ($ Millions)
Figure 17. Global Muscarinic Acetylcholine Receptor Market Size Market Share by Application in 2021
Figure 18. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Player in 2021
Figure 19. Global Muscarinic Acetylcholine Receptor Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Muscarinic Acetylcholine Receptor Market Size 2017-2022 ($ Millions)
Figure 21. APAC Muscarinic Acetylcholine Receptor Market Size 2017-2022 ($ Millions)
Figure 22. Europe Muscarinic Acetylcholine Receptor Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size 2017-2022 ($ Millions)
Figure 24. Americas Muscarinic Acetylcholine Receptor Value Market Share by Country in 2021
Figure 25. Americas Muscarinic Acetylcholine Receptor Consumption Market Share by Type in 2021
Figure 26. Americas Muscarinic Acetylcholine Receptor Market Size Market Share by Application in 2021
Figure 27. United States Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Muscarinic Acetylcholine Receptor Market Size Market Share by Region in 2021
Figure 32. APAC Muscarinic Acetylcholine Receptor Market Size Market Share by Application in 2021
Figure 33. China Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Muscarinic Acetylcholine Receptor Market Size Market Share by Country in 2021
Figure 40. Europe Muscarinic Acetylcholine Receptor Market Size Market Share by Type in 2021
Figure 41. Europe Muscarinic Acetylcholine Receptor Market Size Market Share by Application in 2021
Figure 42. Germany Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size Market Share by Application in 2021
Figure 50. Egypt Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Muscarinic Acetylcholine Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 56. APAC Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 57. Europe Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 59. United States Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 60. Canada Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 63. China Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 64. Japan Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 65. Korea Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 67. India Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 68. Australia Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 69. Germany Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 70. France Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 71. UK Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 72. Italy Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 73. Russia Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 74. Spain Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 77. Israel Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Muscarinic Acetylcholine Receptor Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
